Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
CM-1500 · 2 trials · 2 indications
| Arm | Type | Description |
|---|---|---|
| Blood draw | ACTIVE_COMPARATOR | CM1500 with blood draw |
| No blood draw | SHAM_COMPARATOR | CM 1500 with no blood draw |
| Name | Type | Description |
|---|---|---|
| CM1500 | DEVICE | blood volume monitor |
| CM-1500 | DEVICE | Blood Volume Monitor |
Inclusion Criteria: * healthy volunteer * between 18 to 50 years of age * weight between 157 to 220 lbs Exclusion Criteria: * unstable or untreated cardia disease * alcohol consumption in 24 hours prior to screening * tobacco use in 4 hours prior to screening * pregnancy * infection * Hemoglobin ...
| Company | Ticker | Trials | Lead Phase | Drugs |
|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | VRTX | 1 | PHASE3 | CTX001 |
| Molecular Partners AG Sponsored ADR | MOLN | 1 | PHASE1 | MP0533 monotherapy, Part 1 |
| Abbott Laboratories | ABT | 2 | N/A | Undisclosed |
| Sangamo Therapeutics, Inc. | SGMO | 1 | - | BIVV003, ST-400 |
CM-1500 is an investigational device being developed for blood loss monitoring. It is designed to evaluate blood volume changes during blood draws in healthy subjects. The device is currently in Phase 1 clinical development and has not been approved by regulatory authorities.
CM-1500 is being developed by Zynex, Inc., a company traded on the NASDAQ under the ticker ZYXI. The company is conducting clinical trials to evaluate the device's performance in monitoring blood loss.
CM-1500 is in Phase 1 clinical development. Two Phase 1 trials have been completed, both involving healthy volunteers. The device is investigational and has not received regulatory approval for commercial use.
CM-1500 has been evaluated in two completed Phase 1 trials: NCT01646060, which enrolled 10 healthy male subjects, and NCT01834612, which enrolled 20 healthy adult volunteers. Both studies were conducted in the United States and involved blood draws.
CM-1500 is the device evaluated in clinical trials under the name Zynex Blood Volume Monitor. The trials NCT01646060 and NCT01834612 both reference the CM-1500 in their titles, indicating they refer to the same device.